EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Controlled release formulation



Controlled release formulation



Proceedings of the 6th international congress of pesticide chemistry; Pesticide science and biotechnology: 223-230



This review of the theory, development and application of controlled release pesticide formulations enumerates the advantages of controlled release, examines the polymers used for controlled release formulation and their interaction with pesticides, lists commercial controlled release products with details of their a.i., formulation material and structure and explanatory notes on microencapsulated formulations, and accesses prospective future lines of research.

(PDF emailed within 1 workday: $29.90)

Accession: 001554973

Download citation: RISBibTeXText



Related references

Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation. European Journal of Clinical Pharmacology 33 Suppl: S15-S18, 1988

Comparison of pharmacokinetics between sarpogrelate hydrochloride immediate-release formulation and controlled-release formulation. International Journal of Clinical Pharmacology and Therapeutics 51(2): 114-119, 2013

Pharmacokinetic comparison study of two dexibuprofen products: Controlled release formulation of HM-DER tablet and immediate release formulation of Daxfen (R) tablet in healthy male subjects.. 2008

Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer. 79(7): 1428-1437, 1997

Bioequivalence study of a new once-a-day controlled-release alfuzosin formulation with the 5 mg twice daily formulation. Journal of Urology 163(4 Suppl ): 306, April, 2000

Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain. Journal of Pain and Symptom Management 23(4): 292-300, 2002

Pharmacokinetic and pharmacodynamic characteristics of a controlled-release formulation of trazodone versus the conventional formulation in healthy volunteers. Italian Journal of Neurological Sciences 14(6): 443-449, 1993

Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters. International Journal of Pharmaceutics 505(1-2): 61-68, 2016

Cardiovascular safety of the oral controlled absorption system (OCAS) formulation of tamsulosin compared to the modified release (MR) formulation. European Urology Supplements 4(2): 53-60, 2005

Development of controlled-release pesticide formulations utilizing natural polymeric compounds: 1. Controlled-release fungicide formulation utilizing starch as polymer matrix. Research Reports of the Rural Development Administration (Suweon) 34(2 CROP PROT.): 106-110, 1992

Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics. Acta Psychiatrica Scandinavica. Supplementum 358: 45-47, 1990

Formulation of sustained release products dissolution and diffusion controlled release from gelatin films. International Journal of Pharmaceutics (Kidlington) 20(1-2): 87-98, 1984

Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism. Die Pharmazie 66(9): 677-683, 2011

Designed formulation based on α-tocopherol anchored on chitosan microspheres for pH-controlled gastrointestinal controlled release. Colloids and Surfaces. B, Biointerfaces 96: 8-13, 2012